This article characterizes products formed by the interaction of purified apolipoprotein (apo) A-I and human fibroblasts. Fibroblasts were incubated with different concentrations of purified apoA-I (1 to 30 mu g/mL) in tissue culture medium for different periods of time (0 to 24 hours). The medium was then characterized by one- (agarose) and two-dimensional (agarose :polyacrylamide nondenaturing gradient gel) electrophoresis. At any given concentration of apoA-I, the rate of cellular cholesterol efflux appeared linear over 24 hours. Incubating purified apoA-I with fibroblasts for 4 hours, we detected five pre-alpha lipoproteins with particle sizes between 114 and 684 kDa. Formation of pre-alpha lipoproteins was concentration-dependent. At low concentrations (below 5 mu g/mL apoA-I), all purified apoA-I (with pre-beta mobility) was converted to pre-alpha lipoproteins. At higher concentrations (greater than 5 mu g/mL apoA-I), more apoA-I remained with pre-beta mobility. The pre-alpha lipoproteins were characterized by colocalization of apoA-I particles with C-14-cholesterol and P-32-phospholipids. Results showed that the pre-alpha particle of lowest molecular weight contained phospholipid and apoA-I but no cholesterol. The remaining pre-alpha particles contained all three substances. When pre-alpha particles were subjected to ultracentrifugation, all particles floated at d<1.21 g/mL with some of the smallest phospholipid apoA-I only particles being present in the d>1.21 g/mL fraction. Based on these results, we postulated that in the first stages of reverse cholesterol transport, pre-alpha lipoproteins are formed by the interaction of lipid free apoA-I and peripheral cells.
机构:
Mt Sinai Sch Med, Atherothrombosis Res Unit, Zena & Michael A Wiener Cardiovasc Inst, New York, NY 10029 USAMt Sinai Sch Med, Atherothrombosis Res Unit, Zena & Michael A Wiener Cardiovasc Inst, New York, NY 10029 USA
Santos-Gallego, Carlos G.
Giannarelli, Chiara
论文数: 0引用数: 0
h-index: 0
机构:
Mt Sinai Sch Med, Atherothrombosis Res Unit, Zena & Michael A Wiener Cardiovasc Inst, New York, NY 10029 USAMt Sinai Sch Med, Atherothrombosis Res Unit, Zena & Michael A Wiener Cardiovasc Inst, New York, NY 10029 USA
Giannarelli, Chiara
Badimon, Juan Jose
论文数: 0引用数: 0
h-index: 0
机构:
Mt Sinai Sch Med, Atherothrombosis Res Unit, Zena & Michael A Wiener Cardiovasc Inst, New York, NY 10029 USAMt Sinai Sch Med, Atherothrombosis Res Unit, Zena & Michael A Wiener Cardiovasc Inst, New York, NY 10029 USA
机构:
Univ Tokushima, Grad Sch Pharmaceut Sci, Inst Hlth Biosci, Tokushima 7708505, JapanUniv Tokushima, Grad Sch Pharmaceut Sci, Inst Hlth Biosci, Tokushima 7708505, Japan
Handa, Daisuke
Kimura, Hitoshi
论文数: 0引用数: 0
h-index: 0
机构:
Univ Tokushima, Grad Sch Pharmaceut Sci, Inst Hlth Biosci, Tokushima 7708505, JapanUniv Tokushima, Grad Sch Pharmaceut Sci, Inst Hlth Biosci, Tokushima 7708505, Japan
Kimura, Hitoshi
Oka, Tatsuya
论文数: 0引用数: 0
h-index: 0
机构:
Univ Tokushima, Grad Sch Pharmaceut Sci, Inst Hlth Biosci, Tokushima 7708505, JapanUniv Tokushima, Grad Sch Pharmaceut Sci, Inst Hlth Biosci, Tokushima 7708505, Japan
Oka, Tatsuya
Takechi, Yuki
论文数: 0引用数: 0
h-index: 0
机构:
Univ Tokushima, Grad Sch Pharmaceut Sci, Inst Hlth Biosci, Tokushima 7708505, JapanUniv Tokushima, Grad Sch Pharmaceut Sci, Inst Hlth Biosci, Tokushima 7708505, Japan
Takechi, Yuki
Okuhira, Keiichiro
论文数: 0引用数: 0
h-index: 0
机构:
Univ Tokushima, Grad Sch Pharmaceut Sci, Inst Hlth Biosci, Tokushima 7708505, JapanUniv Tokushima, Grad Sch Pharmaceut Sci, Inst Hlth Biosci, Tokushima 7708505, Japan
Okuhira, Keiichiro
Phillips, Michael C.
论文数: 0引用数: 0
h-index: 0
机构:
Univ Penn, Perelman Sch Med, Div Translat Med & Human Genet, Translat Res Ctr 11 130, Philadelphia, PA 19104 USAUniv Tokushima, Grad Sch Pharmaceut Sci, Inst Hlth Biosci, Tokushima 7708505, Japan
Phillips, Michael C.
Saito, Hiroyuki
论文数: 0引用数: 0
h-index: 0
机构:
Univ Tokushima, Grad Sch Pharmaceut Sci, Inst Hlth Biosci, Tokushima 7708505, JapanUniv Tokushima, Grad Sch Pharmaceut Sci, Inst Hlth Biosci, Tokushima 7708505, Japan
机构:
Peking Union Med Coll, Key Lab Clin Trial Res Cardiovasc Drugs, State Key Lab Cardiovasc Dis, Minist Hlth,Fuwai Hosp,Natl Ctr Cardiovasc Dis, Beijing 100037, Peoples R China
Chinese Acad Med Sci, Beijing 100037, Peoples R ChinaPeking Union Med Coll, Key Lab Clin Trial Res Cardiovasc Drugs, State Key Lab Cardiovasc Dis, Minist Hlth,Fuwai Hosp,Natl Ctr Cardiovasc Dis, Beijing 100037, Peoples R China
Wang Dong-xue
Liu Hong
论文数: 0引用数: 0
h-index: 0
机构:
Peking Union Med Coll, Key Lab Clin Trial Res Cardiovasc Drugs, State Key Lab Cardiovasc Dis, Minist Hlth,Fuwai Hosp,Natl Ctr Cardiovasc Dis, Beijing 100037, Peoples R China
Chinese Acad Med Sci, Beijing 100037, Peoples R ChinaPeking Union Med Coll, Key Lab Clin Trial Res Cardiovasc Drugs, State Key Lab Cardiovasc Dis, Minist Hlth,Fuwai Hosp,Natl Ctr Cardiovasc Dis, Beijing 100037, Peoples R China
Liu Hong
Yan Li-rong
论文数: 0引用数: 0
h-index: 0
机构:
Peking Union Med Coll, Key Lab Clin Trial Res Cardiovasc Drugs, State Key Lab Cardiovasc Dis, Minist Hlth,Fuwai Hosp,Natl Ctr Cardiovasc Dis, Beijing 100037, Peoples R China
Chinese Acad Med Sci, Beijing 100037, Peoples R ChinaPeking Union Med Coll, Key Lab Clin Trial Res Cardiovasc Drugs, State Key Lab Cardiovasc Dis, Minist Hlth,Fuwai Hosp,Natl Ctr Cardiovasc Dis, Beijing 100037, Peoples R China
Yan Li-rong
Zhang Ye-ping
论文数: 0引用数: 0
h-index: 0
机构:
Peking Union Med Coll, Key Lab Clin Trial Res Cardiovasc Drugs, State Key Lab Cardiovasc Dis, Minist Hlth,Fuwai Hosp,Natl Ctr Cardiovasc Dis, Beijing 100037, Peoples R China
Chinese Acad Med Sci, Beijing 100037, Peoples R ChinaPeking Union Med Coll, Key Lab Clin Trial Res Cardiovasc Drugs, State Key Lab Cardiovasc Dis, Minist Hlth,Fuwai Hosp,Natl Ctr Cardiovasc Dis, Beijing 100037, Peoples R China
Zhang Ye-ping
Guan Xiao-yuan
论文数: 0引用数: 0
h-index: 0
机构:
Peking Union Med Coll, Key Lab Clin Trial Res Cardiovasc Drugs, State Key Lab Cardiovasc Dis, Minist Hlth,Fuwai Hosp,Natl Ctr Cardiovasc Dis, Beijing 100037, Peoples R China
Chinese Acad Med Sci, Beijing 100037, Peoples R ChinaPeking Union Med Coll, Key Lab Clin Trial Res Cardiovasc Drugs, State Key Lab Cardiovasc Dis, Minist Hlth,Fuwai Hosp,Natl Ctr Cardiovasc Dis, Beijing 100037, Peoples R China
Guan Xiao-yuan
Xu Zhi-min
论文数: 0引用数: 0
h-index: 0
机构:
Peking Union Med Coll, Key Lab Clin Trial Res Cardiovasc Drugs, State Key Lab Cardiovasc Dis, Minist Hlth,Fuwai Hosp,Natl Ctr Cardiovasc Dis, Beijing 100037, Peoples R China
Chinese Acad Med Sci, Beijing 100037, Peoples R ChinaPeking Union Med Coll, Key Lab Clin Trial Res Cardiovasc Drugs, State Key Lab Cardiovasc Dis, Minist Hlth,Fuwai Hosp,Natl Ctr Cardiovasc Dis, Beijing 100037, Peoples R China
Xu Zhi-min
Jia You-hong
论文数: 0引用数: 0
h-index: 0
机构:
Peking Union Med Coll, Key Lab Clin Trial Res Cardiovasc Drugs, State Key Lab Cardiovasc Dis, Minist Hlth,Fuwai Hosp,Natl Ctr Cardiovasc Dis, Beijing 100037, Peoples R China
Chinese Acad Med Sci, Beijing 100037, Peoples R ChinaPeking Union Med Coll, Key Lab Clin Trial Res Cardiovasc Drugs, State Key Lab Cardiovasc Dis, Minist Hlth,Fuwai Hosp,Natl Ctr Cardiovasc Dis, Beijing 100037, Peoples R China
Jia You-hong
Li Yi-shi
论文数: 0引用数: 0
h-index: 0
机构:
Peking Union Med Coll, Key Lab Clin Trial Res Cardiovasc Drugs, State Key Lab Cardiovasc Dis, Minist Hlth,Fuwai Hosp,Natl Ctr Cardiovasc Dis, Beijing 100037, Peoples R China
Chinese Acad Med Sci, Beijing 100037, Peoples R ChinaPeking Union Med Coll, Key Lab Clin Trial Res Cardiovasc Drugs, State Key Lab Cardiovasc Dis, Minist Hlth,Fuwai Hosp,Natl Ctr Cardiovasc Dis, Beijing 100037, Peoples R China